Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies 2021 | The landscape of cell therapy for solid tumors

Sven Kili, MD, Antion Biosciences SA, Geneva, Switzerland, talks on the current challenges related to the development of cell therapies for solid tumors. He underlines the combined efforts from industry and academia to improve access to the tumor microenvironment, control different cell types and gain better access into the tumor without causing harm to patients. A wide range of strategies are currently being investigated to address these obstacles which include the use of different vectors and cell types, as well as adjuvant approaches. This interview took place at the Advanced Therapies Congress & Expo 2021.


Sven Kili has the following disclosures:
Antion Biosciences – CEO;
Sven Kili Consulting – Principal;
CCRM – Board Member;
UK Innovation Hubs – Steering Committee Chair;
LGC Corporation – SAB Member;
ISCT – BM&I Committee Chair & 2022 Annual Meeting co-chair;
BIA – CGTAC Chair;
Xintela AB – Board Member;
UCL MSc in Manufacturing & Commercialisation of Cell & Gene Therapes – Steering Committee chair